Induction of Cellular Senescence by Insulin-like Growth Factor Binding Protein-5 through a p53-dependent Mechanism
Open accessThe DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Abstract
The insulin-like growth factor (IGF) signaling pathway plays a crucial role in the regulation of cell growth, differentiation, apoptosis, and aging. IGF-binding proteins (IGFBPs) are important members of the IGF axis. IGFBP-5 is up-regulated during cellular senescence in human dermal fibroblasts and endothelial cells, but the function of IGFBP-5 in cellular senescence is unknown. Here we show that IGFBP-5 plays important roles in the regulation of cellular senescence. Knockdown of IGFBP-5 in old human umbilical endothelial cells (HUVECs) with IGFBP-5 micro-RNA lentivirus caused partial reduction of a variety of senescent phenotypes, such as changes in cell morphology, increases in cell proliferation, and decreases in senescence-associated β-galactosidase (SA-β-gal) staining. In addition, treatment with IGFBP-5 protein or up-regulation of IGFBP-5 in young cells accelerates cellular senescence, as confirmed by cell proliferation and SA-β-gal staining. Premature senescence induced by IGFBP-5 up-regulation in young cells was rescued by knockdown of p53, but not by knockdown of p16. Furthermore, atherosclerotic arteries exhibited strong IGFBP-5–positive staining along intimal plaques. These results suggest that IGFBP-5 plays a role in the regulation of cellular senescence via a p53-dependent pathway and in aging-associated vascular diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STAT3 was similarly described to be essential for both the early ROS increase, as well as the later senescence-associated-β-galactosidase activity, through STAT3-regulated soluble factor insulin-like growth factor binding protein 5 in both human fibroblasts (Udono et al., 2012) and vascular endothelial cells (Kim et al., 2007).”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Kim et al., 2007
In the citing paper
“In turn, metabolic and signaling changes seen in diabetes, such as high circulating glucose, altered lipid metabolism, and growth hormone axis perturbations, can promote senescent cell formation.”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [41]
In the citing paper
“The ability of multiple individual components of this pathway to induce senescence has been recently shown, including growth hormone, IGF-1, and IGF binding protein 5 (IGFBP5) (27,28,41).”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [41]
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · cited 1×
“Normal somatic cells cultured in vitro have a limited ability to divide and then enter a state of irreversible proliferative arrest, termed replicative senescence ( Hayflick and Moorhead, 1961 ).”
BackgroundA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“SA--gal activity in cells was measured as described previously (Dimri et al., 1995).”
MethodOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“such as Ras (Serrano et al., 1997) or Raf (Zhu et al.”
BackgroundSenescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 1×
“Accumulating evidence implicates the tumor suppressors, p53, p16, and Rb, as the common major effectors of cellular senescence in normal somatic cells (Beausejour et al., 2003; Campisi, 2005).”
BackgroundIGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109 · cited 1×
“, 2003) or IGF1R (Holzenberger et al., 2003) increased life span.”
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,750 · cited 2×
“The IGFBPs comprise a family of six proteins, IGFBP-1 to -6, that bind to IGFs with high affinity (Firth and Baxter, 2002).”
Backgroundp53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457 · cited 1×
“Accumulating evidence implicates the tumor suppressors, p53, p16, and Rb, as the common major effectors of cellular senescence in normal somatic cells (Beausejour et al., 2003; Campisi, 2005).”
BackgroundThe signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046 · cited 2×
“Accumulating evidence suggests that p53 and p16/Rb tumor suppressor pathways are key regulators of the senescence response (Ferbeyre et al., 2002; Ben-Porath and Weinberg, 2005).”
BackgroundInduction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869 · cited 2×
“, 1997), and PAI-1 and IGFBP-3 are transcriptional targets of p53 (Buckbinder et al., 1995; Zhao et al., 2000).”
BackgroundSenescence of human fibroblasts induced by oncogenic Raf
Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826 · cited 1×
“Irreversible growth arrest is also induced in primary cells by the expression of activated oncogenes such as Ras (Serrano et al., 1997) or Raf ( Zhu et al., 1998 ), by activation of tumor suppressor genes (Tyner et al., 2002; Jacobs and de Lange, 2004).”
BackgroundNPAT links cyclin E–Cdk2 to the regulation of replication-dependent histone gene transcription
Zhao, J., Kennedy, B. K., Lawrence, B. D., Barbie, D. A., Matera, A. G., Fletcher, J. A., & Harlow, E. (2000) · Genes & Development · doi:10.1101/gad.827700 · Cited by 665 · cited 1×
“IGFBP-5 binds to PAI-1, which partially protects IGFBP-5 from proteolysis (Nam et al., 1997), and PAI-1 and IGFBP-3 are transcriptional targets of p53 (Buckbinder et al., 1995; Zhao et al., 2000).”
BackgroundSenescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells.
Chen, Q., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4130 · Cited by 641
Kortlever, R. M., Higgins, P. J., & Bernards, R. (2006) · Nature Cell Biology · doi:10.1038/ncb1448 · Cited by 637 · cited 7×
“Human umbilical vein endothelial cells (HUVECs) and endothelial cell basal medium-2 (EBM-2) containing several growth factors and supplements (EGM-2) were purchased from Cambrex Bio Science (Walkersville, MD). p16- or p53-null mouse embryo fibroblasts (MEFs) were provided by Dr. H. W. Lee (Yonsei University, Korea).”
BackgroundInfluentialAnalysis of p53-regulated gene expression patterns using oligonucleotide arrays
Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W. H., Tom, E., Mack, D. H., & Levine, A. J. (2000) · Genes & Development · doi:10.1101/gad.14.8.981 · Cited by 634 · cited 2×
“, 1997), and PAI-1 and IGFBP-3 are transcriptional targets of p53 (Buckbinder et al., 1995; Zhao et al., 2000).”
BackgroundEvolutionary medicine: from dwarf model systems to healthy centenarians?
Longo, V. D., & Finch, C. E. (2003) · Science · doi:10.1126/science.1077991 · Cited by 575 · cited 2×
“Although a variety of evidence suggests that insulin/ IGF signaling pathways are important in aging and longevity of many organisms (Kenyon, 2001; Longo and Finch, 2003), and IGFBPs are important components of these signaling pathways, the role of IGFBPs in senescence was not well understood.”
BackgroundReplicative Senescence: Implications for in Vivo Aging and Tumor Suppression
Smith, J. R., & Pereira-Smith, O. M. (1996) · Science · doi:10.1126/science.273.5271.63 · Cited by 547 · cited 1×
“, 2000), and show altered gene expression (Smith and Pereira-Smith, 1996).”
BackgroundJones, J. I., Gockerman, A., Busby, W. H., Camacho-Hubner, C., & Clemmons, D. R. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.3.679 · Cited by 538 · cited 2×
“, 1994), ECM proteins (Jones et al., 1993; Gui and Murphy, 2001), and inorganic bone matrix hydroxyapatite (Campbell and Andress, 1997).”
BackgroundA Conserved Regulatory System for Aging
Kenyon, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00306-3 · Cited by 528
Coschigano, K. T., Holland, A. N., Riders, M. E., List, E. O., Flyvbjerg, A., & Kopchick, J. J. (2003) · Endocrinology · doi:10.1210/en.2003-0374 · Cited by 510 · cited 1×
“Repression of insulin/IGF1 signal pathway by deletion of growth hormone receptor (Shimokawa et al., 2002; Coschigano et al., 2003) or IGF1R (Holzenberger et al.”
BackgroundCHEN, Q. M., BARTHOLOMEW, J. C., CAMPISI, J., ACOSTA, M., REAGAN, J. D., & AMES, B. N. (1998) · Biochemical Journal · doi:10.1042/bj3320043 · Cited by 445
Andress, D. L., & Birnbaum, R. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41695-x · Cited by 343 · cited 1×
“independent IGFBP actions were also reported to be important for the regulation of IGFBP activity (Andress and Birnbaum, 1992; Valentinis et al., 1995).”
BackgroundValentinis, B. (1995) · Molecular Endocrinology · doi:10.1210/me.9.3.361 · Cited by 327 · cited 1×
“independent IGFBP actions were also reported to be important for the regulation of IGFBP activity (Andress and Birnbaum, 1992; Valentinis et al., 1995).”
BackgroundOncogenic ras and p53 Cooperate To Induce Cellular Senescence
Ferbeyre, G., de Stanchina, E., Lin, A. W., Querido, E., McCurrach, M. E., Hannon, G. J., & Lowe, S. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3497-3508.2002 · Cited by 290 · cited 2×
“Accumulating evidence suggests that p53 and p16/Rb tumor suppressor pathways are key regulators of the senescence response (Ferbeyre et al., 2002; Ben-Porath and Weinberg, 2005).”
BackgroundCamacho-Hubner, C., Busby, W. H., McCusker, R. H., Wright, G., & Clemmons, D. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49788-3 · Cited by 286
DNA Damage Signaling and p53-dependent Senescence after Prolonged β-Interferon Stimulation
Moiseeva, O., Mallette, F. A., Mukhopadhyay, U. K., Moores, A., & Ferbeyre, G. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-09-0858 · Cited by 252 · cited 6×
“, 2000) that is known to be regulated by ATM kinase (Moiseeva et al., 2006).”
BackgroundInfluentialInsulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis
Beattie, J., Allan, G. J., Lochrie, J. D., & Flint, D. J. (2006) · Biochemical Journal · doi:10.1042/bj20060086 · Cited by 242 · cited 1×
“, 2004) in various experimental systems, which is explained by cell- and context-specific effects and also is suggested by IGF-dependent and -independent mechanisms (Beattie et al., 2006).”
BackgroundChakravarthy, M. V., Abraha, T. W., Schwartz, R. J., Fiorotto, M. L., & Booth, F. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005832200 · Cited by 239
Significant Role for p16INK4a in p53-Independent Telomere-Directed Senescence
Jacobs, J. J. L., & de Lange, T. (2004) · Current Biology · doi:10.1016/j.cub.2004.12.025 · Cited by 237
Morphological Adjustment of Senescent Cells by Modulating Caveolin-1 Status
Cho, K. A., Ryu, S. J., Oh, Y. S., Park, J. H., Lee, J. W., Kim, H.-P., Kim, K. T., Jang, I. S., & Park, S. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402352200 · Cited by 220 · cited 1×
“…IGFBP-5 in young cells caused decreases in phosphorylated Rb at serine 807 and serine 811 and in cyclin A protein levels and increases in p53, p21, p16, and in caveolin-1 (Cho et al., 2004; Cho and Park, 2005) protein levels, which were known to be increased during cellular senescence (Figure 5A).”
BackgroundSelf-citationWagner, M., Hampel, B., Bernhard, D., Hala, M., Zwerschke, W., & Jansen-Dürr, P. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00105-x · Cited by 203 · cited 2×
“Most cells stimulated with rhIGFBP-5 for 2 d were arrested in G1 phase (Figure 4B), which is one of the typical phenotypes in cellular senescence (Wagner et al., 2001).”
BackgroundWebley, K., Bond, J. A., Jones, C. J., Blaydes, J. P., Craig, A., Hupp, T., & Wynford-Thomas, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2803-2808.2000 · Cited by 192 · cited 2×
“The phosphorylation of p53 at serine 15 is a critical senescence-inducible modification (Webley et al., 2000) that is known to be regulated by ATM kinase (Moiseeva et al.”
BackgroundIGF-binding protein-5: flexible player in the IGF system and effector on its own
Schneider, M., Wolf, E., Hoeflich, A., & Lahm, H. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1720423 · Cited by 190 · cited 2×
“Although structurally related, IGFBPs are secreted by many cell types and have differential cell- and tissue-type–dependent expression patterns (Schneider et al., 2002).”
BackgroundSalih, D. A. M., Tripathi, G., Holding, C., Szestak, T. A. M., Gonzalez, M. I., Carter, E. J., Cobb, L. J., Eisemann, J. E., & Pell, J. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400230101 · Cited by 184 · cited 3×
“…Ϯ SD of three independent experiments. play significantly increased neonatal mortality, reduced female fertility, whole-body growth inhibition, and retarded muscle development, suggesting that IGFBP-5 compromises survival, growth, muscle development, and fertility in mice (Salih et al., 2004).”
BackgroundRadiation-Induced Senescence-like Growth Arrest Requires TP53 Function but not Telomere Shortening
Suzuki, K., Mori, I., Nakayama, Y., Miyakoda, M., Kodama, S., & Watanabe, M. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0248:rislga]2.0.co;2 · Cited by 179
Shimokawa, I., Higami, Y., Utsuyama, M., Tuchiya, T., Komatsu, T., Chiba, T., & Yamaza, H. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61173-x · Cited by 140 · cited 1×
“Repression of insulin/IGF1 signal pathway by deletion of growth hormone receptor (Shimokawa et al., 2002; Coschigano et al., 2003) or IGF1R (Holzenberger et al.”
BackgroundButt, A. J., Dickson, K. A., McDougall, F. K., & Baxter, R. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301965200 · Cited by 135 · cited 4×
“, 2003) or through an IGFindependent DNA-damaging pathway (Tonner et al., 2000; Butt et al., 2003; Butt et al., 2005).”
BackgroundInfluentialGiudice, L. C., Irwin, J. C., Dsupin, B. A., Pannier, E., Jin, I. H., Vu, T. H., & Hoffman, A. R. (1993) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137937 · Cited by 131 · cited 1×
“, 2003), and uterine leiomyomas (Giudice et al., 1993), suggesting that IGFBP-5 has an important role in controlling differentiation, cell growth, and apoptosis.”
Background5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation
Catalano, A., Rodilossi, S., Caprari, P., Coppola, V., & Procopio, A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600502 · Cited by 123 · cited 2×
“Recently, cellular senescence induced by several genes or molecules, such as ING2 (Pedeux et al., 2005), -interferon (Moiseeva et al., 2006), or 5-lipoxygenase (Catalano et al., 2005), was shown to be regulated by the p53-dependent pathway.”
BackgroundYoon, I. K., Kim, H. K., Kim, Y. K., Song, I.-H., Kim, W., Kim, S., Baek, S.-H., Kim, J. H., & Kim, J.-R. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.07.002 · Cited by 123 · cited 4×
“The expression levels of IGFBP-3 are increased in senescent human fibroblasts (Goldstein et al., 1993; Yoon et al., 2004) and endothelial cells (Grillari et al.”
BackgroundInfluentialSelf-citationPhysiological changes in ageing skin
CERIMELE, D., CELLENO, L., & SERRI, F. (1990) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1990.tb16120.x · Cited by 122 · cited 1×
“The senescence-accelerated-prone (SAM P10) mice exhibit remarkable increases in the density of collagen fibers in the dermis compared with the senescence-resistant (SAM R1) mice, which is similar to aged human skin (Cerimele et al., 1990).”
BackgroundING2 Regulates the Onset of Replicative Senescence by Induction of p300-Dependent p53 Acetylation
Pedeux, R., Sengupta, S., Shen, J. C., Demidov, O. N., Saito, S., Onogi, H., Kumamoto, K., Wincovitch, S., Garfield, S. H., McMenamin, M., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6639-6648.2005 · Cited by 122 · cited 1×
“Recently, cellular senescence induced by several genes or molecules, such as ING2 (Pedeux et al., 2005), -interferon (Moiseeva et al., 2006), or 5-lipoxygenase (Catalano et al., 2005), was shown to be regulated by the p53-dependent pathway.”
BackgroundNam, T., Busby, W. H., Rees, C., & Clemmons, D. R. (2000) · Endocrinology · doi:10.1210/endo.141.3.7386 · Cited by 121 · cited 1×
“The role of IGFBP-5 in cell growth is complicated, and it has been reported that it can either stimulate (Jones et al., 1993; Nam et al., 2000; Cobb et al., 2004) or inhibit cell proliferation (Butt et al.”
BackgroundThe Sirt1 deacetylase modulates the insulin-like growth factor signaling pathway in mammals
Lemieux, M. E., Yang, X. M., Jardine, K. E., He, X., Jacobsen, K. X., Staines, W. A., Harper, M., & McBurney, M. W. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.04.006 · Cited by 112 · cited 2×
“The loss of Sirt1 protein, an NAD-dependent deacetylase, in mice results in increased expression of IGFBP-1, and a number of the anatomical characteristics of Sirt1-null mice closely resemble those of transgenic mice overexpressing IGFBP-1, suggesting that Sirt1 is part of a regulatory loop that limits IGFBP-1 product…”
BackgroundSubtractive Hybridization of mRNA from early passage and senescent endothelial cells
Grillari, J., Hohenwarter, O., Grabherr, R. M., & Katinger, H. W. D. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00080-2 · Cited by 105 · cited 2×
“, 2004) and endothelial cells (Grillari et al., 2000).”
BackgroundKawachi, S.-I., Takeda, N., Sasaki, A., Kokubo, Y., Takami, K., Sarui, H., Hayashi, M., Yamakita, N., & Yasuda, K. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000154486.03017.35 · Cited by 101 · cited 1×
“However, Kawachi et al. (2005) showed that circulating IGF1 and IGFBP-3 were associated with early carotid atherosclerosis.”
BackgroundDevlin, R. D., Du, Z., Buccilli, V., Jorgetti, V., & Canalis, E. (2002) · Endocrinology · doi:10.1210/en.2002-220129 · Cited by 95 · cited 1×
“IGFBP-5 is also known to play an important role in bone physiology (Devlin et al., 2002; Durant et al., 2004).”
BackgroundInsulin-like growth factor binding proteins in human breast cancer tissue.
Pekonen, F., Nyman, T., Ilvesmäki, V., & Partanen, S. (1992) · PubMed · Cited by 92
Kyoung Kim, H., Kyoung Kim, Y., Song, I.-H., Baek, S.-H., Lee, S.-R., Hye Kim, J., & Kim, J.-R. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.1.4 · Cited by 92 · cited 2×
“Because we reported that FOXO3a levels were decreased in old HDFs, and down-regulation of FOXO3a accelerated cellular senescence in HDFs ( Kyoung Kim et al., 2005 ), FOXO3a level was also measured.”
BackgroundSelf-citationDuan, C., Liimatta, M. B., & Bottum, O. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37147 · Cited by 92 · cited 2×
“K. S. Kim et al. Molecular Biology of the Cell 4550 occur by direct stimulation of IGFBP-5 gene transcription (Duan et al., 1999) or by posttranslational protection from proteolysis via binding to secreted IGFBP-5 protein (Camacho- Hubner et al., 1992).”
BackgroundInsulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells
Marshman, E., Green, K. A., Flint, D. J., White, A. E., Streuli, C. H., & Westwood, M. (2003) · Journal of Cell Science · doi:10.1242/jcs.00263 · Cited by 92 · cited 2×
“IGFBP-5 can enhance apoptosis by modulating IGF-mediated survival (Marshman et al., 2003) or through an IGFindependent DNA-damaging pathway (Tonner et al.”
BackgroundGlycosaminoglycans inhibit degradation of insulin-like growth factor- binding protein-5
Arai, T., Arai, A., Busby, W. H., & Clemmons, D. R. (1994) · Endocrinology · doi:10.1210/endo.135.6.7527332 · Cited by 86 · cited 1×
“Some IGFBPs can interact with biomolecules other than IGFs, including extracellular matrix (ECM) glycosaminoglycans (Arai et al., 1994), ECM proteins (Jones et al.”
BackgroundNam, T., Busby, W. H., & Clemmons, D. R. (1994) · Endocrinology · doi:10.1210/endo.135.4.7523096 · Cited by 82 · cited 1×
“IGFBP proteolysis by specific proteases also reduces the affinity between IGFs and IGFBPs and modulates IGF bioactivity (Nam et al., 1994; Moralez et al., 2003).”
BackgroundInsulin-Like Growth Factor Binding Protein-5 Binds to Plasminogen Activator Inhibitor-I
Nam, T. J. (1997) · Endocrinology · doi:10.1210/en.138.7.2972 · Cited by 80 · cited 1×
“IGFBP-5 binds to PAI-1, which partially protects IGFBP-5 from proteolysis (Nam et al., 1997), and PAI-1 and IGFBP-3 are transcriptional targets of p53 (Buckbinder et al., 1995; Zhao et al., 2000).”
BackgroundHAMPEL, B., FORTSCHEGGER, K., RESSLER, S., CHANG, M., UNTERLUGGAUER, H., BREITWIESER, A., SOMMERGRUBER, W., FITZKY, B., LEPPERDINGER, G., & JANSENDURR, P. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.03.001 · Cited by 78
Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function
Cobb, L. J., Salih, D. A. M., Gonzalez, I., Tripathi, G., Carter, E. J., Lovett, F., Holding, C., & Pell, J. M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01028 · Cited by 75 · cited 2×
“IGFBP-5 is up-regulated during the differentiation of myoblasts (Cobb et al., 2004) and in some tumors, including breast cancers (Pekonen et al.”
BackgroundGui, Y., & Murphy, L. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7472 · Cited by 74 · cited 1×
“, 1994), ECM proteins (Jones et al., 1993; Gui and Murphy, 2001), and inorganic bone matrix hydroxyapatite (Campbell and Andress, 1997).”
BackgroundHampel, B., Wagner, M., Teis, D., Zwerschke, W., Huber, L. A., & Jansen‐Dürr, P. (2005) · Aging Cell · doi:10.1111/j.1474-9726.2005.00180.x · Cited by 69 · cited 1×
“IGFBP-3 accumulation in conditioned medium of senescent fibroblasts contributes to growth arrest of human fibroblasts, and the failure to endocytose IGFBP-3 and the absence of nuclear IGFBP-3 may contribute to the apoptosis resistance of senescent human fibroblasts (Hampel et al., 2005).”
BackgroundColao, A., Spiezia, S., Somma, C. D., Pivonello, R., Marzullo, P., Rota, F., Musella, T., Auriemma, R. S., Martino, M. C. D., & Lombardi, G. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347225 · Cited by 67 · cited 1×
“Colao et al., (2005) reported that circulating IGF1 and IGFBP-3 levels were negatively correlated with common cardiovascular risk factors in healthy subjects, independent of age.”
BackgroundYasuoka, H., Jukic, D. M., Zhou, Z., Choi, A. M. K., & Feghali‐Bostwick, C. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22084 · Cited by 65 · cited 1×
“IGFBP-5 induces skin fibrosis with increased collagen deposition, denser dermal connective tissue, and increased collagen bundle thickness in IGFBP-5-adenovirus–injected mice (Yasuoka et al., 2006).”
BackgroundAllander, S. V., Larsson, C., Ehrenborg, E., Suwanichkul, A., Weber, G., Morris, S. L., Bajalica, S., Kiefer, M. C., Luthman, H., & Powell, D. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34142-x · Cited by 62
McCormick, A., & Campisi, J. (1991) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(91)90144-n · Cited by 60
Sheikh, M. S., Shao, Z., Clemmons, D. R., LeRoith, D., Roberts, C. T., & Fontana, J. A. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80290-6 · Cited by 57 · cited 1×
“, 2004) and in some tumors, including breast cancers (Pekonen et al., 1992; Sheikh et al., 1992), thyroid cancers (Stolf et al.”
BackgroundTonner, E., Allan, G., Shkreta, L., Webster, J., Bruce, C., Whitelaw, A., & Flint, D. J. (2005) · Advances in Experimental Medicine and Biology · doi:10.1007/0-306-46832-8_5 · Cited by 56 · cited 2×
“, 2003) or through an IGFindependent DNA-damaging pathway (Tonner et al., 2000; Butt et al., 2003; Butt et al., 2005).”
BackgroundButt, A. J., Dickson, K. A., Jambazov, S., & Baxter, R. C. (2005) · Endocrinology · doi:10.1210/en.2004-1408 · Cited by 55 · cited 2×
“, 2003) or through an IGFindependent DNA-damaging pathway (Tonner et al., 2000; Butt et al., 2003; Butt et al., 2005).”
BackgroundHydroxyurea induces a senescence-like change of K562 human erythroleukemia cell
Park, J., Jeong, J., Han, J., Kim, D.-I., Gao, Y.-H., Park, S.-C., Rodgers, G. P., & Kim, I.-H. (2000) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050013 · Cited by 54
Goldstein, S., Moerman, E. J., & Baxter, R. C. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041560211 · Cited by 54 · cited 2×
“The expression levels of IGFBP-3 are increased in senescent human fibroblasts (Goldstein et al., 1993; Yoon et al., 2004) and endothelial cells (Grillari et al.”
BackgroundSchuler-Lüttmann, S., Mönnig, G., Enbergs, A., Schulte, H., BREITHARDT, G. E., Assmann, G., Kerber, S., & von Eckardstein, A. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.e10 · Cited by 51 · cited 2×
“IGFBP-3 was reported to be associated with the presence and extent of coronary arteriosclerosis (Schuler-Luttmann et al., 2000) and with the development of carotid atherosclerosis in hypertensive patients (Watanabe et al., 2003).”
BackgroundCaveolin-1 as a prime modulator of aging: a new modality for phenotypic restoration?
Cho, K. A., & Park, S. C. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.09.029 · Cited by 42 · cited 1×
“…IGFBP-5 in young cells caused decreases in phosphorylated Rb at serine 807 and serine 811 and in cyclin A protein levels and increases in p53, p21, p16, and in caveolin-1 (Cho et al., 2004; Cho and Park, 2005) protein levels, which were known to be increased during cellular senescence (Figure 5A).”
BackgroundCampbell, P. G., & Andress, D. L. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.5.e1005 · Cited by 38 · cited 1×
“, 1993; Gui and Murphy, 2001), and inorganic bone matrix hydroxyapatite (Campbell and Andress, 1997).”
BackgroundWatanabe, T., Itokawa, M., Nakagawa, Y., Iguchi, T., & Katagiri, T. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00985-3 · Cited by 37 · cited 2×
“IGFBP-3 was reported to be associated with the presence and extent of coronary arteriosclerosis (Schuler-Luttmann et al., 2000) and with the development of carotid atherosclerosis in hypertensive patients (Watanabe et al., 2003).”
BackgroundBasler, J. W., David, J. D., & Agris, P. F. (1979) · Experimental Cell Research · doi:10.1016/0014-4827(79)90585-8 · Cited by 36 · cited 2×
“Collagen synthesis was also altered in senescent fibroblasts and in fibroblasts from Werner's syndrome patients (Basler et al., 1979).”
BackgroundStolf, B. S., de Carvalho, A. F., Martins, W. K., Runza, F. B., Brun, M., Hirata, R., Neves, E. J., Soares, F. A., Postigo, J., Kowalski, L. P., et al. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00679-1 · Cited by 30
Moralez, A., Busby, W. H., & Clemmons, D. R. (2003) · Endocrinology · doi:10.1210/en.2002-220896 · Cited by 13 · cited 1×
“IGFBP proteolysis by specific proteases also reduces the affinity between IGFs and IGFBPs and modulates IGF bioactivity (Nam et al., 1994; Moralez et al., 2003).”
BackgroundDurant, D., Pereira, R. C., Stadmeyer, L., & CANALIS, E. M. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.04.002 · Cited by 9 · cited 1×
“IGFBP-5 is also known to play an important role in bone physiology (Devlin et al., 2002; Durant et al., 2004).”
Background
Research works printed but not linked: 5
- Campbell P. G., 1997, Am. J. Physiol, 273, E1005
- Gui Y., 2001, J. Clin. Endocrinol. Metab, 86, 2104
- Nam T. J., 1997, Endocrinology, 138, 2972, 10.1210/endo.138.7.5230 · doi:10.1210/endo.138.7.5230 · Paper page
- Pekonen F., 1992, Cancer Res, 52, 5204
- Valentinis B., 1995, Mol. Endocrinol, 9, 361
Cited by
Senescence-messaging secretome: SMS-ing cellular stress
Kuilman, T., & Peeper, D. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2560 · Cited by 909
“Treatment of HUVECs with recombinant IGFBP3 or IGFBP5 is sufficient to slow down proliferation and provoke markers of senescenc”
BackgroundA senescent cell bystander effect: senescence‐induced senescence
Nelson, G., Wordsworth, J., Wang, C., Jurk, D., Lawless, C., Martin‐Ruiz, C., & von Zglinicki, T. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00795.x · Cited by 755
“Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#onlineopen_Terms Accepted for publication 4 January 2012 ª 2012 The Authors Aging Cell ª 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland 345 Aging Cell (2012…”
BackgroundInfluentialIGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
Allard, J. B., & Duan, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00117 · Cited by 515
“Immunostaining for IGFBP-5 protein was dense within atherosclerotic plaques and especially around calcified areas (61).”
BackgroundCellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
Palmer, A. K., Tchkonia, T., LeBrasseur, N. K., Chini, E. N., Xu, M., & Kirkland, J. L. (2015) · Diabetes · doi:10.2337/db14-1820 · Cited by 423
“Another IGFBP member, IGFBP5, has been found to increase during endothelial and fibroblast senescence and may induce cellular senescence on its own through a p53-dependent, p16independent mechanism (41).”
BackgroundCritical pathways in cellular senescence and immortalization revealed by gene expression profiling
Fridman, A. L., & Tainsky, M. A. (2008) · Oncogene · doi:10.1038/onc.2008.213 · Cited by 385
“Significantly, premature senescence was induced when IGFBP5 was overexpressed in human umbilical vein endothelial cells (Seok Kim et al., 2007).”
Background
Metadata
- Authors
- Kim, K. S., Seu, Y. B., Baek, S.-H., Kim, M. J., Kim, K. J., Kim, J. H., & Kim, J.-R.
- Affiliations
- Kyungpook National University (KR)
- *Department of Biochemistry and Molecular Biology,
- Yeungnam University (KR)
- Venue
- Molecular Biology of the Cell
- Published
- 2007-11
- Volume
- 18
- Issue
- 11
- Pages
- 4543-4552
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- PMC
- PMC2043568
- OpenAlex
- W2121682401
- Cited by
- 199
- References
- 76
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 14 · 2023: 10 · 2022: 18 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 10 · 2017: 13 · 2016: 12 · 2015: 13 · 2014: 14 · 2013: 11 · 2012: 8
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Biology of the Cell (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Korea Science and Engineering Foundation (R13-2005-005-01003-0)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- IGFBP-5, cellular senescence, p53, IGF signaling pathway, premature senescence, human umbilical vein endothelial cells, atherosclerosis, intimal plaque, p16, cell proliferation
- MeSH terms
- Cell Cycle, Cells, Cultured, DNA, DNA Damage, Humans, Protein Processing, Post-Translational, Umbilical Cord, Signal Transduction, Up-Regulation, Tumor Suppressor Protein p53, Cellular Senescence, Insulin-Like Growth Factor Binding Protein 5, MicroRNAs, Endothelial Cells, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.